12 Panel Dip Card
12 Panel Dip Cards are a versatile and eye-catching marketing solution designed to present
detailed information in a compact, foldable format. Featuring multiple panels that unfold smoothly,
they allow businesses to showcase products, services, or promotions in an organized and engaging
way. Ideal for brochures, menus, and promotional handouts, these cards combine practicality with a
professional appearance, making them perfect for leaving a lasting impression on customers.
Showing all 3 results
Dip card 12 Panel Detects MDMA, FEN & ADLTX, Serenity Multi-Level Dip Card
ADLTX, AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI/MOR, OXY, THCForensic UseAs low As$1.19 $1.19 - $1.79
12 Panel Drug Test Dip Card with FEN & Adulterants
ADLTX, AMP, BAR, BUP, BZO, COC, EtG, MDMA, MET, MTD, OPI/MOR, OXY, THCForensic UseAs low As$1.19 $1.19 - $1.79
Dip card 12 Panel Detects PCP & THC, FDA approved and CLIA waived for as low as $1.19
AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THCCLIA WAIVED, FDA ApprovedAs low As$1.19 $1.19 - $1.79
Bulk Pricing that Cuts the Budget in Half
Priority Shipping For Bulk Orders.
Dedicated Wholesale Representative.
Quality That Is Reliable For the Nation.
Key Features of 12 Panel Dip Card
- Rapid results – preliminary screening complete in 5 to 10 minutes for 12 types of drugs and variants
- Fully observed collection – tamper-resistant process with no restroom needed
- On-site ready – no lab, no special equipment, no collection facility required
- Detects recent use – identifies drug use within the past 24 to 48 hours
- Minimal training required – straightforward administration for any staff member
- Individually sealed sterile devices – hygienic single-use packaging for every test
12 Panel Multi Dip Card Test specifications
| Code | Substance | Cutoff | What It Catches |
|---|---|---|---|
| AMP | Amphetamines | 1000 ng/mL | Adderall, Vyvanse, Dexedrine and prescription or illicit amphetamines |
| BAR | Barbiturates | 300 ng/mL | Phenobarbital, butalbital, secobarbital — CNS depressant class distinct from BZO |
| BUP | Buprenorphine | 10 ng/mL | Suboxone, Subutex — detects MAT compliance at therapeutic concentrations a standard OPI strip misses |
| BZO | Benzodiazepines | 300 ng/mL | Xanax, Valium, Klonopin, Ativan, Restoril — full benzodiazepine class |
| COC | Cocaine | 300 ng/mL | Cocaine and crack cocaine — detects urinary metabolite benzoylecgonine 2 to 4 days post-use |
| EtG | Ethyl Glucuronide | 300 ng/mL | Alcohol metabolite — detects consumption up to 80 hours post-use. Present only on the EtG/ADLTX card |
| FEN | Fentanyl | 20 ng/mL | Illicit fentanyl and primary fentanyl analogs — added to SAMHSA federal panels July 2025. Present only on the FEN/ADLTX card |
| MDMA | Methylenedioxymethamphetamine | 500 ng/mL | Ecstasy, Molly — independent panel; present across all three cards |
| MET | Methamphetamine | 1000 ng/mL | Crystal meth, street methamphetamine — dedicated panel independent of AMP |
| MTD | Methadone | 300 ng/mL | Methadone maintenance — does not appear on standard OPI strip; present across all three cards |
| OPI/MOR | Opiates / Morphine | 300 ng/mL | Heroin, codeine, morphine — present across all three cards |
| OXY | Oxycodone | 100 ng/mL | OxyContin, Percocet — dedicated panel that standard OPI strips miss; present across all three cards |
| PCP | Phencyclidine | 25 ng/mL | PCP (angel dust) — present only on the CLIA Waived card |
| THC | Marijuana / Cannabis | 50 ng/mL | Cannabis, edibles, concentrates — present across all three cards |
| ADLTX — Specimen Validity / Adulterant Checks (present on FUO cards only — 3 independent checks) | |||
| pH | Urine pH | 3.0 to 11.0 | Flags samples outside normal urinary pH range, indicating possible chemical adulteration |
| SG | Specific Gravity | 1.001 to 1.030 | Detects diluted or substituted specimens outside the normal urinary concentration range |
| CRE | Creatinine | 2 to 300 mg/dL | Confirms biological origin of specimen; very low creatinine indicates substituted or severely diluted urine |
Red codes are not present on all three cards. ADLTX rows apply to FUO cards only. All cutoffs are standard Serenity panel thresholds.
Choose Your 12 Panel Configuration
| Product | All Panels | Type | Unique Panel | From |
|---|---|---|---|---|
| 12 Panel with FEN and ADLTX Best for corrections, drug courts, probation |
AMP  | BAR  | BUP  | BZO  | COC FEN/20ng  | MDMA  | MET  | MTD OPI/MOR  | OXY  | THC + pH  | Specific Gravity  | Creatinine |
Forensic Use Only | FEN + 3 ADLTX | $1.19 |
| 12 Panel with EtG and ADLTX Best for MAT, sober living, alcohol monitoring |
AMP  | BAR  | BUP  | BZO  | COC EtG/300ng  | MDMA  | MET  | MTD OPI/MOR  | OXY  | THC + pH  | Specific Gravity  | Creatinine |
Forensic Use Only | EtG + 3 ADLTX | $1.19 |
| 12 Panel CLIA Waived with PCP Best for workplace, clinical, pain management |
AMP  | BAR  | BUP  | BZO  | COC MDMA  | MET  | MTD  | OPI/MOR OXY  | PCP/25ng  | THC |
CLIA Waived FDA Approved |
PCP only (no ADLTX) | $1.19 |
All three cards require a separate urine specimen container. Results in 5 minutes. 99% accuracy. Presumptive positives on FUO cards require GC-MS or LC-MS/MS confirmation. For bulk pricing call 561-897-9238 or email [email protected].
Easy Steps To Use The 12 Panel Dip Card
Step 1 — Collect
Remove the drug test cup from its sealed pouch and use it as soon as possible. Have the subject provide a urine sample directly into the cup, filling to the indicated line.
Step 2 — Dip & Wait
At 2–4 minutes, verify the temperature of the specimen using the built-in temperature strip. A green indicator confirms the sample is valid and within the acceptable range of 90–100°F.
Step 3 — Read
Peel back the label when ready to interpret results. Read results within 5 minutes of collection. Do not read results after 8 minutes, as the extended window may affect accuracy.
Positive
Two colored bands appear — one in the control region (C) and one in the test region (T). This indicates no drug was detected above the cutoff level.
Negative
Two colored bands appear, one in the control region (C) and another in the test region (T) for the drug in question.
Invalid
The control band fails to appear entirely. Discard the test and retest with a fresh cup within 3 minutes. If the problem persists, contact your distributor.
Three 12 Panel Dip Cards: Fentanyl Detection, Alcohol Monitoring, and CLIA Waived Clinical Standard All as low sa $1.19
The 12 panel dip card category from 12 Panel Now contains three distinct Serenity Multi-Level Dip Cards, all at $1.19 per card in bulk. Every card covers the complete classical substance baseline: stimulants (AMP, MET, MDMA), opioids (BUP, MTD, OPI/MOR, OXY), sedatives (BAR, BZO), cocaine, and THC. The difference between the three lies in the one or two specialized additions each card carries, and whether the card includes the three-marker ADLTX specimen validity check.
What separates the three 12 panel configurations:
12 Panel with FEN and ADLTX — Forensic Use Only
Panels: AMP, BAR, BUP, BZO, COC, FEN, MDMA, MET, MTD, OPI/MOR, OXY, THC plus pH, Specific Gravity, Creatinine validity checksThis card adds two things the standard CLIA Waived card lacks: Fentanyl detection at 20 ng/mL and three urine specimen validity markers (pH, Specific Gravity, and Creatinine). The FEN panel is the federally mandated addition as of July 2025 per SAMHSA Mandatory Guidelines for Federal Workplace Drug Testing. The ADLTX validity checks flag diluted, substituted, or chemically adulterated specimens before results are recorded. Programs in forensic, court, or correctional settings where specimen integrity documentation is a regulatory or legal requirement use this card as their primary 12 panel FUO format. The combination of FEN detection and built-in specimen validity makes it the most comprehensive forensic-use card in this range.
12 Panel with EtG and ADLTX — Forensic Use Only
Panels: AMP, BAR, BUP, BZO, COC, EtG, MDMA, MET, MTD, OPI/MOR, OXY, THC plus pH, Specific Gravity, Creatinine validity checksThis card swaps FEN for Ethyl Glucuronide (EtG) at 300 ng/mL, which detects alcohol consumption for up to 80 hours after use. Like the FEN card above, it also includes the three ADLTX specimen validity checks. This card is built for programs where alcohol abstinence monitoring is the primary clinical or forensic documentation priority alongside the standard substance baseline: sober living facilities, MAT programs monitoring concurrent alcohol use, and court programs with documented alcohol-related supervision orders. Programs that need both FEN and EtG from a dip card can run both cards from the same specimen, or consider the 13 panel dip card range, which integrates both into a single card.
12 Panel CLIA Waived with PCP — CLIA Waived, FDA Approved
Panels: AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, PCP, THC. No ADLTX. CLIA Waived and FDA ApprovedThe only CLIA Waived card in this range. It replaces EtG, FEN, and the ADLTX checks with PCP (Phencyclidine) at 25 ng/mL, giving this card the cleanest classical 12 panel profile: the complete stimulant, opioid, sedative, and cannabis baseline plus PCP, all under CLIA Waived and FDA Approved certification. For workplace programs, clinical documentation settings, pain management clinics, and any context where CLIA Waived status and professional classification are the regulatory requirement, this is the appropriate card. It does not detect fentanyl, alcohol, or check for specimen adulteration. For all those functions, the FUO cards above are the correct choice.
The Role of ADLTX in Forensic Drug Testing
The two FUO cards in this range include ADLTX, three specimen validity tests that check pH, Specific Gravity, and Creatinine alongside the 12 drug panels. These are not drug panels. They check the physical characteristics of the urine specimen itself to determine whether it has been diluted with water, chemically adulterated to interfere with the drug panels, or substituted with a non-biological fluid. A specimen that fails an ADLTX check can be flagged as invalid before any drug panel result is recorded, preventing specimen manipulation from masking a positive result. For forensic programs where specimen integrity documentation has legal significance, the ADLTX validity checks on the FUO cards are a critical operational component. The CLIA Waived card does not include ADLTX. Programs that need specimen validity checking on a CLIA Waived test can run the ADLTX separately using a standalone adulteration test strip.
12 Panel Dip Card Features: Complete Baseline Coverage
Three 12 Panel Dip Cards from 12 Panel Now: Complete Substance Baseline with FEN, EtG, or PCP Added, All at $1.19 in Bulk with Same-Day Shipping: The 12 panel dip card range covers the full professional substance baseline across every configuration. The three cards differ only in the specialized panel each one carries: Fentanyl with ADLTX validity checks, EtG with ADLTX validity checks, or PCP in CLIA Waived format. Every card at the same $1.19 bulk price.
- Full Classical 12 Panel Baseline on Every Card: MDMA, BAR, BUP, MTD and OXY All Standard: All three cards carry the complete professional baseline most commonly needed across clinical and forensic programs. MDMA at 500 ng/mL as its own dedicated panel, Barbiturates (BAR) at 300 ng/mL for the sedative class, Buprenorphine (BUP) at 10 ng/mL to detect Suboxone compliance, Methadone (MTD) at 300 ng/mL for methadone programs, and Oxycodone (OXY) at 100 ng/mL for prescription opioid detection. None of these require a separate add-on. Every 12 panel dip card in this range includes all five as standard across every configuration.
- ADLTX Specimen Validity on Both FUO Cards: pH, Specific Gravity and Creatinine Built In: The two Forensic Use Only cards include the three-marker ADLTX specimen validity check at no additional cost. The pH check flags chemically adulterated samples. The Specific Gravity check detects diluted or substituted specimens. The Creatinine check confirms biological origin of the specimen. All three run simultaneously alongside the 12 drug panels from the same dip event. For forensic programs where specimen integrity has legal or regulatory documentation significance, these three validity markers prevent specimen manipulation from concealing a positive drug result. No separate adulteration strip is needed.
- FEN at 20ng on the Forensic Card: Federal Compliance Since July 2025 in a $1.19 Dip Format: The 12 Panel FEN/ADLTX Dip Card adds Fentanyl at 20 ng/mL alongside the full 12 panel baseline and three ADLTX checks. Per SAMHSA Mandatory Guidelines, fentanyl was added to federal workplace drug testing panels effective July 2025. For forensic programs that need both FEN detection and specimen validity documentation in a single dip card test, this configuration provides both for $1.19 per card in bulk.
- EtG at 300ng on the Alcohol Card: 80-Hour Alcohol Metabolite Detection with Built-In Specimen Validity: The 12 Panel EtG/ADLTX Dip Card detects alcohol use via Ethyl Glucuronide for up to 80 hours post-consumption alongside the full 12 panel drug baseline and three ADLTX specimen validity checks. For sober living, MAT, and forensic programs running weekly urine collection, EtG at 300 ng/mL closes the alcohol monitoring gap across the inter-test interval. The ADLTX checks on the same card ensure specimen validity is confirmed alongside the alcohol and drug result in a single test event.
- CLIA Waived with PCP for Clinical Documentation: The Professional Standard at $1.19: The 12 Panel CLIA Waived Dip Card is the only configuration in this range with CLIA Waived and FDA Approved certification, carrying PCP at 25 ng/mL alongside the full 12 panel classical baseline. Per CMS CLIA regulations, CLIA Waived devices may be used for clinical documentation without external laboratory confirmation in settings holding a Certificate of Waiver. For workplace, clinical, and pain management programs where regulatory classification and PCP coverage define the selection criteria, this is the correct card.
- Results in 5 Minutes, One-Step Dip Process, No Instruments Required: All three cards use the same procedure. Remove from sealed foil pouch. Dip the absorptive end into a fresh urine specimen for 10 to 15 seconds. Lay flat for 5 minutes. Two lines on a drug panel means negative. One control line only means presumptive positive. ADLTX markers read alongside drug panels simultaneously. Requires a separate specimen collection container. Results can be photocopied for record keeping.
- Bulk Wholesale from $1.19 with Same-Day Shipping and a 10% Price Beat Guarantee: All three 12 panel dip cards start at $1.19 per card in bulk with tiered wholesale pricing at every volume level. Mix and match all three configurations on a single order. Send your current supplier's pricing to [email protected] and we beat it by 10%. Same-day shipping on orders placed before 3:00 PM EST. Free shipping on qualifying bulk orders.
- Full OEM and Private Label Support Across All Three Cards: All three 12 panel dip cards are available with OEM and private label support including custom packaging, pouch design, and card branding for distributors, treatment organizations, and court and correctional supply networks.
Contact for Bulk 12 Panel Dip Card Orders, Wholesale Pricing and Private Label:Â 561-897-9238Â |Â [email protected]
Check other product variations
for Multi Dip Cards
From everyday staples to specialty products:
- Multi Strips
- 5 Panel Dip Cards
- 10 Panel Dip Cards
- 12 Panel Dip Cards
- 14 Panel Dip Cards
- 19 Panel Dip Cards
10 Panel Dip
13 Dip Panel
12 Panel Dip
Dip Cards
12 Panel Dip Cards Available for Private Labeling and High Volume Orders
- Three configurations, one price: 12 Panel FEN/ADLTX (Forensic), 12 Panel EtG/ADLTX (Forensic), and 12 Panel CLIA Waived with PCP — all at $1.19 in bulk
- Both FUO cards include built-in ADLTX specimen validity checks (pH, Specific Gravity, Creatinine) alongside the full 12 drug panels in a single dip. No separate adulteration strip needed
- CLIA Waived and FDA Approved on the PCP card for clinical documentation in certified settings. FUO classification on the FEN and EtG cards for forensic and court use
- Mix all three configurations on one order. Beat-by-10% price guarantee on any competing quote. Send current supplier pricing to [email protected]
- Same-day shipping on all orders before 3:00 PM EST. Free shipping on qualifying bulk orders. Full OEM and private label support for distributors, treatment programs, drug courts, corrections, and sober living
The 12 panel dip card from 12 Panel Now covers every professional substance at the established SAMHSA cutoff levels, then adds one critical specialty panel per card. FEN for fentanyl surveillance with specimen validity. EtG for alcohol abstinence monitoring with specimen validity. PCP for the CLIA Waived professional standard. Three cards. Three program types. One price. Order today with same-day shipping.
Order 12 Panel Dip Cards in Bulk Today 561-897-9238 [email protected]
For fewer panels see our 10 panel dip cards. For higher panel count with Kratom, Gabapentin, K2, or additional emerging substances, see our 13 panel dip cards and 19 panel dip cards.
What 12 Panel Now Offers:
220,000 Sq. Ft. Mega
Warehouse
We operate one of the largest drug-testing fulfillment centers in the country, stocked and ready to ship every day.
Lowest Wholesale Pricing. Highest Commissions. Period.
We aggressively price our products so you win more deals, while paying industry-leading commissions to our partners.
Same-Day Blind Drop Shipping
We ship directly to your customers — no branding, no invoices, no paper trail back to us. You keep the relationship. We do the heavy lifting.
Private Label Available
Want your own brand on the box? We’ve got you covered.
Build equity while selling proven products.
Real-Time Partner Portal
Track every order, commission, and customer in one clean dashboard. No guessing. No spreadsheets. Total transparency.
Where 12 Panel Dip Cards Are Used
| Setting | Best Card | Primary Applications | Why This Card |
| Drug Courts and Probation | 12 Panel FEN/ADLTX | Court-ordered comprehensive substance monitoring, fentanyl detection for supervised individuals in opioid supply environments, specimen validity documentation for legal proceedings | FEN at 20 ng/mL is the July 2025 SAMHSA federal mandate addition. The built-in ADLTX check provides documented specimen integrity evidence essential in legal proceedings where results may be challenged. Per NADCP best practice standards, comprehensive substance monitoring including emerging opioids is recommended. |
| Sober Living and Residential Programs | 12 Panel EtG/ADLTX | Weekly resident accountability screening with 80-hour alcohol metabolite detection to close the inter-test gap, specimen validity checking to prevent dilution-based evasion, full drug panel alongside | EtG at 300 ng/mL covers 80 hours of alcohol metabolite detection, bridging the full weekly collection interval. The ADLTX check prevents specimen dilution used to evade positive results. Programs running weekly collections need both features simultaneously. The 12 Panel EtG/ADLTX card delivers both for $1.19 with no additional adulteration strip required. |
| Workplace and Clinical Programs | 12 Panel CLIA Waived with PCP | Pre-employment, random, and post-accident workplace screening with CLIA Waived documentation, clinical screening in pain management and MAT settings where PCP is part of the standard panel requirement | CLIA Waived status allows clinical use without laboratory confirmation in settings holding a Certificate of Waiver. PCP at 25 ng/mL is present in many standard workplace and clinical 12 panel protocols. The CLIA Waived card is the only configuration in this range that meets the regulatory classification for clinical documentation settings. The full 12 panel baseline including MDMA, BAR, BUP, MTD, and OXY is standard on this card. |
| Correctional Facilities | 12 Panel FEN/ADLTX | Institutional drug screening with documented specimen validity, fentanyl supply contamination detection, deterrence of specimen dilution or chemical adulteration attempts | Correctional programs need both fentanyl detection and specimen validity documentation. Fentanyl has been confirmed in drug supply in all 50 US states per CDC overdose surveillance data. The ADLTX built-in check prevents inmates from using dilution or adulteration to pass tests. Both are addressed in the same $1.19 FEN/ADLTX card without the need for a separate specimen validity strip. |
| MAT and Addiction Treatment Programs | 12 Panel EtG/ADLTX or CLIA Waived | BUP and MTD compliance monitoring alongside concurrent substance screening, alcohol abstinence monitoring via EtG for programs with alcohol co-occurring use documentation, CLIA Waived card for programs that require clinical documentation certification | BUP at 10 ng/mL and MTD at 300 ng/mL are both standard across all three cards, making the 12 panel format ideal for MAT compliance monitoring. Programs needing EtG for alcohol monitoring alongside MAT substances use the EtG/ADLTX card. Programs requiring CLIA Waived documentation alongside BUP and MTD use the CLIA Waived card. Per SAMHSA MAT guidelines, concurrent substance monitoring is a compliance requirement. |
Why Forensic Drug Testing Programs Need ADLTX Specimen Validity Built Into Their 12 Panel Dip Card
The two Forensic Use Only 12 panel dip cards from 12 Panel Now address this problem by including three built-in ADLTX specimen validity markers alongside the 12 drug panels in a single dip event. The pH check identifies specimens outside the normal urinary pH range of 4.5 to 8.5, flagging chemical adulteration by acidic or alkaline substances. The Specific Gravity check identifies specimens outside the normal concentration range of 1.003 to 1.030, flagging severely diluted specimens. The Creatinine check confirms biological origin by measuring a metabolic waste product present in genuine urine, with very low creatinine values indicating substituted or severely diluted specimens. All three markers produce results simultaneously alongside the 12 drug panels within 5 minutes of the dip event, without any additional testing equipment or a separate adulteration strip.
For drug courts, corrections facilities, and probation programs where drug test results are used in legal proceedings and may be contested, documented specimen validity is not optional. The ADLTX markers on the 12 Panel FEN/ADLTX and EtG/ADLTX Dip Cards provide that documentation as a built-in component of every test event at the same $1.19 per card bulk price. Programs that need ADLTX validity on a CLIA Waived card can run the CLIA Waived 12 panel card alongside a standalone adulteration test strip from the same collected specimen.
12 Panel Dip Card with Fentanyl: Meeting the July 2025 SAMHSA Workplace Mandate at $1.19 Per Card
In July 2025, the Substance Abuse and Mental Health Services Administration updated the Mandatory Guidelines for Federal Workplace Drug Testing Programs to add fentanyl as a required analyte for federally regulated employees. This was the first expansion of the mandatory federal workplace drug testing panel in over two decades, driven by fentanyl's documented prevalence in the US workforce. Quest Diagnostics 2024 workplace drug testing data showed fentanyl positivity in random workforce tests at 1.13%, more than seven times the pre-employment positive rate, with 60% of fentanyl-positive workforce specimens also testing positive for at least one additional substance.
For programs currently running standard 12 panel dip cards without a FEN panel, the federal mandate creates a compliance gap. The most direct solution for forensic screening programs is the 12 Panel FEN/ADLTX Dip Card from 12 Panel Now, which adds FEN detection at 20 ng/mL alongside the complete 12 panel professional baseline and three built-in ADLTX specimen validity checks, all for $1.19 per card in bulk. The FEN panel at 20 ng/mL aligns with the standard threshold used in federally mandated testing. The ADLTX checks add documented specimen integrity confirmation alongside the FEN result.
Workplace programs that require a CLIA Waived classification rather than Forensic Use Only should note that the CLIA Waived card in this range does not include FEN. Programs needing CLIA Waived FEN detection can add a standalone fentanyl dip card to their CLIA Waived 12 panel test from the same specimen. For programs ready to upgrade their entire cup procurement to include FEN as a built-in panel, the 13 panel cup with FEN from 12 Panel Now integrates fentanyl detection directly into the cup format starting at $1.79 in bulk. Contact 561-897-9238 for guidance on the right FEN testing configuration for your program.
What Does “Forensic Use Only and CLIA” Mean for 12 Panel Dip Cards?
- What it means:CLIA Waived only tests determine program compliance - whether someone violated probation conditions, sober living rules, or custody requirements. They do not diagnose substance use disorder or guide medical treatment. Many courts require laboratory confirmation (GC-MS or LC-MS/MS) before admitting screening results as evidence.All results obtained from CLIA Waived & Fentanyl Drug Test Method tests should be treated as preliminary screening results only and must be confirmed by a certified laboratory using GC-MS (Gas Chromatography-Mass Spectrometry) or LC-MS/MS methodology before any legal, disciplinary, or medical action is taken.
- How results are used:Â Forensic use only tests determine program compliance - whether someone violated probation conditions, sober living rules, or custody requirements. They do not diagnose substance use disorder or guide medical treatment. Many courts require laboratory confirmation (GC-MS or LC-MS/MS) before admitting screening results as evidence.
- What it means:Â The product has not undergone FDA 510(k) clearance - the premarket notification process for medical devices. The FDA exercises enforcement discretion over these products because forensic settings have evidentiary protections (rules of evidence, chain of custody, confirmation requirements) not present in clinical settings.
12 Panel Dip Card frequently asked questions
The main difference is the specialty panel included. The FEN/ADLTX card detects fentanyl, while the EtG/ADLTX card detects alcohol consumption through the EtG metabolite. Both include specimen validity checks for pH, specific gravity, and creatinine.
Yes. The 12 Panel FEN/ADLTX Dip Card includes a dedicated fentanyl panel with a cutoff level of 20 ng/mL, providing sensitive screening for fentanyl exposure.
The ADLTX system includes pH, Specific Gravity, and Creatinine checks. These markers help identify diluted, substituted, or chemically adulterated urine samples.
Yes. The FEN/ADLTX and EtG/ADLTX versions include specimen validity testing that can flag samples showing signs of dilution, substitution, or adulteration.
Yes. All three configurations include a Buprenorphine panel with a 10 ng/mL cutoff for monitoring Suboxone and Subutex use.
Including both panels allows programs to monitor compliance with multiple Medication-Assisted Treatment (MAT) medications using a single screening device.
The ADLTX-equipped versions include built-in specimen validity checks that help identify attempts to dilute, substitute, or chemically alter urine samples.
Yes. Customers can mix and match different 12 Panel configurations within the same order while still qualifying for volume-based pricing.
Its CLIA Waived and FDA Approved status allows eligible healthcare settings to use the test for professional screening and documentation purposes.
Presumptive positive results should be confirmed by a certified laboratory using GC-MS (Gas Chromatography-Mass Spectrometry) or LC-MS/MS testing methods.
The 12 Panel CLIA Waived Dip Card with PCP is typically the preferred option for workplace testing because it is CLIA Waived, FDA Approved, and includes PCP detection alongside the standard drug panel.
Yes. The EtG panel detects Ethyl Glucuronide, an alcohol metabolite that can remain detectable for up to 80 hours after alcohol consumption.
Creatinine helps verify that the specimen is genuine human urine. Extremely low creatinine levels may indicate dilution or specimen substitution.
The 12 Panel CLIA Waived Dip Card includes a dedicated PCP panel with a 25 ng/mL cutoff level.
Yes. Oxycodone has its own dedicated OXY panel, allowing it to be detected independently from the standard OPI/MOR panel
Yes. The inclusion of Buprenorphine, Methadone, Oxycodone, and other commonly monitored substances makes these cards suitable for MAT and recovery programs.
All configurations include AMP, BAR, BUP, BZO, COC, MDMA, MET, MTD, OPI/MOR, OXY, and THC. The specialty panel varies by configuration.
This configuration is commonly used by drug courts, probation departments, correctional facilities, law enforcement agencies, and forensic monitoring programs.
Yes. OEM and private label options are available, allowing distributors and organizations to add custom branding, packaging, and product labeling.
